Consult your healthcare provider in this case
The concentration of semaglutide varies by brand and formulation
Disease areas Science & technology Partnering Sustainable business Careers About us Our products Investors News & media Healthcare professionals Contact us Send us an email
Local Common (1% to 10%): Injection site reactions (subcutaneous formulation) Injection site reactions included administration site reactions, application/instillation site reactions, erythema, induration, inflammation, infusion site reactions, injection site discomfort, injection site pruritus, injection site rash, and irritation
While the drug successfully altered certain biological markers associated with the disease, these biological changes did not result in a measurable preservation of cognitive function for the participants